TLR2 and Parkinson disease: We reviewed the latest evidence that disrupted Toll-like receptor 2 or Toll-like receptor 4 signaling pathway leads to Parkinson’s disease in gut homeostasis and enteric nervous system, as well as gut dysfunction in Parkinson’s disease.